Torys is acting as counsel to Brookfield Reinsurance. On August 18, 2023, Brookfield Reinsurance Ltd. (“Brookfield Reinsurance”) announced its intention to commence an offer whereby holders...
Brookfield Reinsurance’s Exchange Offer
The Rounds’ C$5.1 Million Series A Round
Torys LLP acted for Boondoc Technologies Incorporated on the round. Boondoc Technologies Incorporated, doing business as The Rounds, closed a Series A preferred share investment of up to...
Evotec’s Partnership with Sernova
Torys LLP acted as counsel to Evotec. On May 17, 2022, Evotec SE and Sernova Corp. announced a partnership in the field of diabetes. Both Companies will leverage...
Triumvira Immunologics’ $100 Million Series A Financing Round
Latham & Watkins, Torys LLP and Goodwin represented Triumvira Immunologics in the transaction. Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell...
LQT Therapeutics’ $19 Million Series A Financing
Torys LLP represented Amplitude Ventures in the financing. On August 10, 2021, LQT Therapeutics, Inc. completed a US$19 million Series A financing. The financing was led by...